SCHEMBL8418004

SCHEMBL8418004

Cc1nc(Cl)c(Cl)n1CCCCN1CCN(c2ncccn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.48
DRD2 P14416 6/20 0.48
HTR2A P28223 4/20 0.48
DRD3 P35462 5/20 0.47
DRD1 P21728 2/20 0.47
DRD5 P21918 1/20 0.47
HRH3 Q9Y5N1 4/20 0.46
PARP1 P09874 1/20 0.45
DRD4 P21917 1/20 0.45
HTR7 P34969 1/20 0.45
ALDH1A1 P00352 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474002 0.86 SIGMAR1 (0.53) HTR1ADRD2
SCHEMBL8115703 0.86 HTR1A (0.41) HTR1ADRD2HTR2AHTR7ALDH1A1
Citric Acid SCHEMBL9025029 0.86 HRH3 (0.42) HTR1ADRD2HTR2ADRD3HRH3
Hydrochloric Acid SCHEMBL8115889 0.85 HTR1A (0.40) HTR1ADRD2HTR2AHTR7ALDH1A1
SCHEMBL8416472 0.82 KDM4E (0.61) HTR1ADRD2HTR2ADRD3DRD1
SCHEMBL8416503 0.82 HTR1A (0.61) HTR1ADRD2HTR2ADRD3HTR7
SCHEMBL8113668 0.81 ALDH1A1 (0.47) HTR1AHTR7ALDH1A1
SCHEMBL8416539 0.79 HTR2A (0.55) HTR1ADRD2HTR2ADRD3HTR7
SCHEMBL8416338 0.78 P2RX7 (0.63) HTR1ADRD2HTR2ADRD3DRD1
SCHEMBL8416455 0.77 HTR1A (0.62) HTR1ADRD2HTR2ADRD3HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP claimed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP claimed
EP-0502786-B1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives ESTEVE LABOR DR (ES) 1996-04-24 EP disclosed
EP-0497659-B1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs ESTEVE LABOR DR (ES) 1996-04-10 EP disclosed
US-5382586-A Tranquilizers LABORATORIOS DEL DR. ESTEVE S.A. (ES) 1995-01-17 US disclosed
US-5292739-A Aryl(or heteroaryl) piperazinylalkylazole derivatives, their preparation and their application as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1994-03-08 US disclosed
US-5227486-A Reaction of spiro-quaternary ammonium compound LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1993-07-13 US disclosed
EP-0502786-A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-09-09 EP disclosed
EP-0497659-A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1992-08-05 EP disclosed